These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2159187)

  • 1. Overview of ifosfamide in small cell and non-small cell lung cancer.
    Johnson DH
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):24-30. PubMed ID: 2159187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of ifosfamide in small cell lung cancer.
    Ettinger DS
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):59-67. PubMed ID: 1329214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ifosfamide-based chemotherapy for previously treated lung cancer patients.
    Chen YM; Liu JM; Wu MF; Wu HW; Lin WC; Tsai CM; Perng RP; Whang-Peng J
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jul; 61(7):389-96. PubMed ID: 9699391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ifosfamide in non-small cell lung cancer: a review.
    Eberhardt W; Niederle N
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):40-8. PubMed ID: 1329211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ifosfamide in small cell lung cancer.
    Einhorn LH
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):19-21. PubMed ID: 2539644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ifosfamide in non-small cell lung cancer.
    Johnson DH
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):7-10. PubMed ID: 8677453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ifosfamide with mesna uroprotection in the management of lung cancer.
    Holoye PY; Glisson BS; Lee JS; Dhingra HM; Murphy WK; Umsawasdi T; Levy JK; Jeffries D; Raber MN; Hong WK
    Am J Clin Oncol; 1990 Apr; 13(2):148-55. PubMed ID: 2156418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of ifosfamide in small cell lung cancer.
    Loehrer PJ
    Semin Oncol; 1996 Jun; 23(3 Suppl 7):40-4. PubMed ID: 8711501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer.
    Evans WK; Stewart D; Logan D; Maroun J; Goss G; Shepherd FA; Latreille J; Warner E; Dahrouge S
    Semin Oncol; 1992 Dec; 19(6 Suppl 12):51-6. PubMed ID: 1336622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ifosfamide in the treatment of non-small cell lung cancer.
    Ettinger DS
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):31-8. PubMed ID: 2539646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ifosfamide in the treatment of small cell lung cancer.
    Ettinger DS
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):2-6. PubMed ID: 8677443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with ifosfamide and etoposide combination chemotherapy in extensive-disease small-cell lung cancer.
    Wu MF; Perng RP; Chen YM; Liu JM; Yang SL; Whang-Peng J
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Aug; 60(2):67-73. PubMed ID: 9360330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel approaches with ifosfamide in small cell lung cancer.
    Thatcher N; Lind M; De Campos E; Cerny T
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):68-77. PubMed ID: 1329215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.
    Ettinger DS
    Semin Oncol; 1995 Feb; 22(1 Suppl 2):23-7. PubMed ID: 7846538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.
    Shirinian M; Lee JS; Dhingra HH; Greenberg J; Hong WK
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):49-53. PubMed ID: 1329212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Ifosfamide plus N-acetylcysteine in the treatment of small cell and non-small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial".
    Holoye PY
    Cancer Treat Rep; 1987 Apr; 71(4):431-2. PubMed ID: 3030548
    [No Abstract]   [Full Text] [Related]  

  • 17. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
    Strauss GM; Lynch TJ; Elias AD; Jacobs C; Herbst R; Leong T; Lynch C; Kwiatkowski DJ; Carey RW; Grossbard ML; Skarin AT
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies.
    Hoffman PC; Masters GA; Drinkard LC; Krauss SA; Samuels BL; Golomb HM; Vokes EE
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):11-5. PubMed ID: 8677441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer.
    Strauss GM; Lynch TJ; Elias AD; Jacobs C; Kwiatkowski DJ; Shulman LN; Carey RW; Grossbard ML; Jauss S; Sugarbaker DJ
    Semin Oncol; 1995 Aug; 22(4 Suppl 9):70-4. PubMed ID: 7544029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.